Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Consun Pharmaceutical Group Ltd. ( (HK:1681) ) has provided an update.
Consun Pharmaceutical Group Ltd. has announced the composition of its Board of Directors and the roles within its four established committees. This organizational update may influence the company’s governance and strategic direction, potentially impacting stakeholders and the company’s positioning in the pharmaceutical industry.
The most recent analyst rating on (HK:1681) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.
More about Consun Pharmaceutical Group Ltd.
Consun Pharmaceutical Group Ltd. is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. The company focuses on the development, manufacturing, and distribution of pharmaceutical products.
Average Trading Volume: 2,346,318
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.36B
Learn more about 1681 stock on TipRanks’ Stock Analysis page.